Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreServices
Alpha Genesis runs GLP and non-GLP rodent studies in mice and rats, spanning pharmacology, PK/PD, toxicology, immunology, and surgical and interventional models, with experienced technical teams and veterinary oversight at every stage.
Alpha Genesis conducts GLP and non-GLP rodent studies in rats (Rattus norvegicus) and mice (Mus musculus) for pharmaceutical, biotechnology, academic, and government sponsors. Programs range from early proof-of-concept pharmacology and PK/PD profiling to dose-ranging, tolerability, toxicology, and immunology, with study designs matched to your scientific and regulatory objectives.
Studies are run by experienced technical teams under veterinary oversight, with SOP-driven procedures, daily clinical observations, and clearly defined humane endpoints. Whether you need non-GLP exploratory work to guide lead selection or GLP-aligned documentation for IND-enabling decisions, we will scope the design, timeline, and deliverables that fit your program.
And if a program later moves into NHPs, the same team can carry it forward, so what we learn about your compound in rodents informs the work that follows.
Drug developers seeking efficient, welfare-compliant rodent CRO services for early-stage pharmacology, safety screening, and IND-enabling study support.
Biotech sponsors requiring responsive rodent in vivo capabilities, including novel biologics, cell and gene therapy support, and immunology studies in defined mouse and rat models.
NIH-funded investigators, federal agencies, and defense research programs requiring compliant in vivo rodent research conducted under institutional animal welfare standards.
Teams that need responsive, well-run rodent studies, from a single focused experiment to an ongoing series, with quick turnaround on study design and feasibility.
Our rodent preclinical platform covers a broad spectrum of in vivo study types for mice and rats, available to research clients and matched to your protocol and timeline.
Rodent studies at Alpha Genesis utilize mouse and rat models, plus additional rodent species on request, selected to fit the scientific objectives of each program.
Inbred, outbred, and transgenic mouse models for pharmacology, PK/PD, immunology, oncology, and custom in vivo studies. Strain selection is guided by study objectives and sponsor protocol requirements.
Rat models are commonly selected for toxicology, dose-ranging, PK/PD, and surgical or interventional studies where larger body mass and vascular access are scientifically advantageous. Common strains include Sprague-Dawley and Wistar, among others.
Beyond standard mouse and rat strains, Alpha Genesis can support additional rodent species when a program calls for them, including Syrian hamsters for infectious-disease and respiratory models, guinea pigs, gerbils, and cotton rats. Species, strain, and sourcing are confirmed through feasibility review to fit your model and endpoints.
Rodent study execution at Alpha Genesis is supported by trained technical staff, defined SOPs, and veterinary oversight at every stage.
Rodent study quality at Alpha Genesis rests on rigorous husbandry, controlled housing, and experienced rodent technicians working under veterinary oversight. Preventive health management, daily clinical observations, and clearly defined humane endpoints support both animal welfare and study reproducibility, with SOP-driven operations and audit-ready documentation throughout. The program operates under a federally recognized animal-care and compliance framework, including AAALAC accreditation, USDA registration, OLAW Assurance, and IACUC oversight, and supports both GLP and non-GLP work, with GLP-aligned documentation for IND-enabling decisions.
Rigorous husbandry, controlled housing, and veterinary oversight, backed by AAALAC accreditation, produce healthier rodents with more consistent baselines and more reproducible data across study cohorts.
Dosing, sampling, surgery, and in-life monitoring are performed by a dedicated rodent team with deep hands-on experience, producing cleaner procedures, steadier baselines, and more reproducible data.
Veterinary staff provide medical direction throughout study conduct, from protocol review and anesthetic management to clinical observation interpretation and welfare intervention decisions.
We help match the model and design to your endpoints, choosing among inbred, outbred, or transgenic mice and common rat strains, rather than forcing a program into a template.
Sponsors work directly with experienced study coordinators and scientific staff, so protocol questions, feasibility, and data queries are answered by people who understand preclinical research.
Alpha Genesis brings an established compliance infrastructure and government and commercial study execution history to its rodent platform. This operational foundation translates directly into reliable timelines, audit-ready documentation, and study quality.
We support mouse and rat studies across all common strains: inbred, outbred, and transgenic. We source from qualified vendors meeting our health standards and confirm the specific strain for your program during protocol review.
Submit a protocol for review or contact our team to discuss study feasibility, strain availability, timeline, and GLP or non-GLP study options.
